R & D Masterclass
, This one-day course features pharma sharing their approach to R&D processes to inform and assist not only attendees' own R&D efforts but also the timing and manner of their outreach to investors and pharma. Learn how to plan go-no go decision points that align with investment.
You may participate in-person or virtually.
Session
8:45AM-9:00AM Welcome & Introductions with Mary Howard, FirstxFounder, Chao Zheng, Boehringer Ingelheim
9:00AM-9:45 Meaningful Milestones in an R&D Program with Bijan Biyat, Gerard Honig, Otsuka
9:45 –10:30 AM Pharma Decision Metrics for Research Spending John Pennett, EisnerAmper, Chao Zheng, Boehringer Ingelheim
10:30-10:45AM Break
10:45-11:30 AM R&D Milestone Exercise with Bijan Biyat and Brendan Rae, Innovene Therapeutics
11:30AM-12:10 PM GO/NO GO Decision points by R&D stage with Lambert Edelmann, Click Therapeutics and Chao Zheng, Boehringer Ingelheim
12:10PM-12:45PM Alternative Early Exits with Martin Krusin, Entero Therapeutics, Moderator Uday Khire, Cheminpharma, and Choukri Ben Mamoun, Yale University and Virtus Therapeutics, Chris Garabedian, Xontogeny and PXV Fund
12:45-1:30PM Lunch
1:30PM-2:15 How Research is Optimized by Operations with Chat Desilva, BioCentriq, Arijit Bhowmick, Insitro
2:15PM-3:15PM Patents and IP Strategy with Craig Kenesky, Wilson Sonsini
3:15-3:30PM Break
3:30-4:15PM How Research is Optimized by Incubators with Glennis Mehra, Biolabs, Hamdi Cavusoglu, Merck, and Vallen Graham, Novetur
4:15PM-5:00PM Case Study – How did this deal go forward?
5:00PM-5:10PM Wrap Up
We are grateful for the sponsors of the Elab R&D Masterclass 2025, Wilson Sonsini and innolabs:
5:00-7:00PM Networking reception immediately following at innolabs
View last year's R&D Masterclass to see a detailed schedule and panelists.